Vetter, Valentin Max
Sommerer, Yasmine
Kalies, Christian Humberto
Spira, Dominik
Bertram, Lars
Demuth, Ilja https://orcid.org/0000-0002-4340-2523
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (842/7-1)
H2020 European Research Council
Cure Alzheimer's Fund
Bundesministerium für Bildung und Forschung (#01UW0808, #16SV5536K, #16SV5537, #16SV5538, #16SV5837, #01GL1716A, #01GL1716B)
Charité - Universitätsmedizin Berlin
Article History
Received: 15 February 2022
Accepted: 26 April 2022
First Online: 13 May 2022
Declarations
:
: All participants gave written informed consent. The medical assessments at baseline and follow-up were conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Charité – Universitätsmedizin Berlin (approval numbers EA2/029/09 and EA2/144/16).
: The medical assessments at baseline and follow-up were registered in the German Clinical Trials Registry as DRKS00009277 and DRKS00016157.
: The authors declare no competing interests.